Generative AI: Ethical, Legal, and Technical Questions; Markkula Center for Applied Ethics, Santa Clara University, Tuesday, May 16, 2023 12 Noon Pacific/3 PM Eastern

 

Join us May 16th at noon for an online panel discussion on ethical, legal, and technical questions related to generative AI.

Generative AI: Ethical, Legal, and Technical Questions   Noon to 1:00 p.m. Pacific Tuesday, May 16, 2023   "As artists, composers, and other “content creators” and intellectual property owners use generative AI tools or decry their development, many legal and ethical issues arise. In this panel discussion, a copyright law expert, an AI researcher who is also a composer and music performer, and a multi-disciplinary visual artist (all of whom teach at Santa Clara University) will address some of those questions–from training data collection to fair use, impact on creativity and creative labor, the balancing of various rights, and our ability to assess and respond to fast-moving technologies."

Register to Attend the Webinar

Copyright Office Sets Sights on Artificial Intelligence in 2023; Bloomberg Law, December 29, 2022

Riddhi Setty, Bloomberg Law; Copyright Office Sets Sights on Artificial Intelligence in 2023

"The US Copyright Office over the next year will focus on addressing legal gray areas that surround copyright protections and artificial intelligence, amid increasing concerns that IP policy is lagging behind technology. 

“Developments are happening so quickly and so pervasively in so many different fields that I think in a way that is taking up most of the oxygen in the room these days,” Shira Perlmutter, register of copyrights and the office’s director, told Bloomberg Law in an interview."

Frustrated by vaccine inequity, a South African lab rushes to replicate Moderna’s shot; The Washington Post, November 28, 2021

Lesley Wroughton, The Washington Post ; Frustrated by vaccine inequity, a South African lab rushes to replicate Moderna’s shot

"At the World Trade Organization (WTO), trade ministers had been scheduled to begin meetings Tuesday over a contentious proposal by South Africa and India to temporarily waive intellectual property rights on coronavirus vaccines and therapies or find a way to allow developing countries to access the technologies. The meeting has been postponed because of the omicron variant. No new date has been set...

African countries have historically depended on Western donors and United Nations-backed programs such as the vaccine alliance known as Gavi, a partnership of donors and pharmaceutical companies that buys vaccines at lower prices and makes them available to countries that need them. Covax, a vaccine marketplace that was meant to secure coronavirus inoculations for developing countries, has struggled to access enough supplies during the pandemic...

Moderna has said it will not prosecute those found to be infringing on its covid-related patents during the pandemic, which amounts to an informal waiver, said Marie-Paule Kieny, a French virologist who chairs the U.N.-backed Medicine Patent Pool, which is part of the WHO’s efforts in Africa.

The concern with a waiver, Kieny said, is what happens once the pandemic ends. Any broader waiver agreed on at the WTO talks would likely have a time limit, she said, without a commitment from the drugmakers to enter into licensing agreements.

She said companies should negotiate now with drugmakers such as Moderna to reach formal licensing agreements before the pandemic is over."